Literature DB >> 25002037

White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels.

José Luis Molinuevo1, Pablo Ripolles2, Marta Simó3, Albert Lladó1, Jaume Olives1, Mircea Balasa1, Anna Antonell1, Antoni Rodriguez-Fornells4, Lorena Rami5.   

Abstract

The aim of this study was to use diffusion tensor imaging measures to determine the existence of white matter microstructural differences in the preclinical phases of Alzheimer's disease, assessing cognitively normal older individuals with positive amyloid β protein (Aβ42) levels (CN_Aβ42+) on the basis of normal cognition and cerebrospinal fluid Aβ42 levels below 500 pg/mL. Nineteen CN_Aβ42+ and 19 subjects with Aβ42 levels above 500 pg/mL (CN_Aβ42-) were included. We encountered increases in axial diffusivity (AxD) in CN_Aβ42+ relative to CN_Aβ42- in the corpus callosum, corona radiata, internal capsule, and superior longitudinal fasciculus bilaterally, and also in the left fornix, left uncinate fasciculus, and left inferior fronto-occipital fasciculus. However, no differences were found in other diffusion tensor imaging indexes. Cognitive reserve scores were positively associated with AxD exclusively in the CN_Aβ42+ group. The finding of AxD alteration together with preserved fractional anisotropy, mean diffusivity, and radial diffusivity indexes in the CN_Aβ42+ group may indicate that, subtle axonal changes may be happening in the preclinical phases of Alzheimer's disease, whereas white matter integrity is still widely preserved.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cerebrospinal fluid; Cognition; Diagnosis; Diffusion tensor imaging; Preclinical phases

Mesh:

Substances:

Year:  2014        PMID: 25002037     DOI: 10.1016/j.neurobiolaging.2014.05.027

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  41 in total

1.  Clinically silent Alzheimer's and vascular pathologies influence brain networks supporting executive function in healthy older adults.

Authors:  Brian T Gold; Christopher A Brown; Jonathan G Hakun; Leslie M Shaw; John Q Trojanowski; Charles D Smith
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

Review 2.  Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.

Authors:  S Duke Han; Caroline P Nguyen; Nikki H Stricker; Daniel A Nation
Journal:  Neuropsychol Rev       Date:  2017-05-11       Impact factor: 7.444

3.  Everyday functioning and cognitive correlates in healthy older adults with subjective cognitive concerns.

Authors:  Courtney McAlister; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2016-05-31       Impact factor: 3.535

4.  Global White Matter Diffusion Characteristics Predict Longitudinal Cognitive Change Independently of Amyloid Status in Clinically Normal Older Adults.

Authors:  Jennifer S Rabin; Rodrigo D Perea; Rachel F Buckley; Taylor E Neal; Randy L Buckner; Keith A Johnson; Reisa A Sperling; Trey Hedden
Journal:  Cereb Cortex       Date:  2019-03-01       Impact factor: 5.357

5.  Synergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults.

Authors:  Jennifer S Rabin; Rodrigo D Perea; Rachel F Buckley; Keith A Johnson; Reisa A Sperling; Trey Hedden
Journal:  Neurobiol Aging       Date:  2019-05-16       Impact factor: 4.673

6.  Genetic and environmental influences on cortical mean diffusivity.

Authors:  Jeremy A Elman; Matthew S Panizzon; Donald J Hagler; Christine Fennema-Notestine; Lisa T Eyler; Nathan A Gillespie; Michael C Neale; Michael J Lyons; Carol E Franz; Linda K McEvoy; Anders M Dale; William S Kremen
Journal:  Neuroimage       Date:  2016-11-15       Impact factor: 6.556

Review 7.  Insulin resistance in Alzheimer's disease.

Authors:  Thomas Diehl; Roger Mullins; Dimitrios Kapogiannis
Journal:  Transl Res       Date:  2016-12-13       Impact factor: 7.012

8.  Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.

Authors:  Ashwati Vipin; Kwun Kei Ng; Fang Ji; Hee Youn Shim; Joseph K W Lim; Ofer Pasternak; Juan Helen Zhou
Journal:  Hum Brain Mapp       Date:  2019-01-03       Impact factor: 5.038

9.  Age and Alzheimer's pathology disrupt default mode network functioning via alterations in white matter microstructure but not hyperintensities.

Authors:  Christopher A Brown; Yang Jiang; Charles D Smith; Brian T Gold
Journal:  Cortex       Date:  2018-04-19       Impact factor: 4.027

10.  White matter hyperintensity microstructure in amyloid dysmetabolism.

Authors:  Lisa F Kalheim; Atle Bjørnerud; Tormod Fladby; Kjetil Vegge; Per Selnes
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.